Epicardial Application of Hydrogel with Amiodarone for Prevention of Postoperative Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting

被引:14
作者
Bockeria, O. L. [1 ,2 ]
Kanametov, T. N. [1 ,2 ]
Shvartz, V. A. [1 ,2 ]
Sokolskaya, M. A. [1 ,2 ]
Zhuginisov, D. Sh [1 ,2 ]
Sanakoev, M. K. [1 ,2 ]
Bockeria, L. A. [1 ,2 ]
机构
[1] Bakulev Natl Med Res Ctr Cardiovasc Surg, Moscow, Russia
[2] Bakulev Natl Med Res Ctr Cardiovasc Surg, Dept Surg Treatment Interact Pathol, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
Amiodarone-releasing hydrogel; Coronary artery bypass surgery; Postoperative atrial fibrillation; Prevention; Clinical study; MANAGEMENT;
D O I
10.1007/s12265-019-09905-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to assess the safety and efficacy of local epicardial application of amiodarone-releasing hydrogel for prevention of postoperative atrial fibrillation (POAF) in patients after coronary artery bypass grafting. Patients were randomized into two groups: with the application of amiodarone-releasing hydrogel and the control group. It included 60 patients (47 males, 13 females) (mean age of 62 +/- 8.5). POAF incidence differences were statistically significant between two groups: in the study group, the POAF incidence was 3.3%, while in the control group, the POAF incidence was 37% (p < 0.001). Statistically significant differences were revealed in the PQ interval duration. The risk of POAF incidence was calculated using the Cox regression model: the age and the application of amiodarone-releasing hydrogel application were statistically significant. Hospital length of stay in two groups was also different (p < 0.001). The age and the application of amiodarone-releasing hydrogel were statistically significant for POAF incidence.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 20 条
[1]  
Allessie MA, 2001, CIRCULATION, V103, P769
[2]  
[Anonymous], ISRN CARDIOLOGY, DOI [10.5402/2011/203179, DOI 10.5402/2011/203179]
[3]  
Bockeria OL, 2017, COR VASA, V59, pE266, DOI 10.1016/j.crvasa.2016.11.003
[4]  
Bockeria O L, 2016, Indian Heart J, V68, P792, DOI 10.1016/j.ihj.2016.04.002
[5]  
Brunton L. L., 2005, GOODMAN GILMANS PHAR, P2021
[6]   Postoperative atrial fibrillation after aortic valve replacement is a risk factor for long-term atrial fibrillation [J].
Carter-Storch, Rasmus ;
Dahl, Jordi S. ;
Christensen, Nicolaj L. ;
Pecini, Redi ;
Sondergard, Eva V. ;
Ovrehus, Kristian Altern ;
Moller, Jacob E. .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (03) :378-385
[7]  
Connolly SJ, 1997, LANCET, V350, P1417
[8]   Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation [J].
Feng, Xiao Dong ;
Wang, Xue Ning ;
Yuan, Xin Hiu ;
Wang, William .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (03) :939-943
[9]   Postoperative atrial fibrillation following cardiac surgery: a persistent complication [J].
Greenberg, Jason W. ;
Lancaster, Timothy S. ;
Schuessler, Richard B. ;
Melby, Spencer J. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 52 (04) :665-672
[10]   Effect of epicardial application of amiodarone-releasing hydrogel on heart rate in an animal model [J].
Kanametov, Teymuraz N. ;
Shvartz, Vladimir A. ;
Oltarzhevskaya, Natalia D. ;
Bockeria, Olga L. .
CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2019, 9 (04) :328-336